fashion -WSS

fashion

author：explore 2025-09-30 00:48:54 - browse：83

JOSEPH PREZIOSO/AFP via Getty Images

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief. But the findings also prompted fresh debate on Tuesday about how widely used the therapy would be should it win regulatory approval.

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. The study also found that the drug was generally safe, with fewer patients on the medication reporting adverse events than those who had taken a placebo. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint. And in the bunionectomy study, the opioid comparator beat VX-548 on pain relief.

“While this study was not explicitly designed to test VX-548 vs. the opioid comparator, this may complicate the prescribing decision in the acute setting, where patients often take a short course of treatment and efficacy is a primary consideration,” Stifel market analyst Paul Matteis wrote in a note to investors, adding that results from three Phase 3 studies were positive overall.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： After traumatic brain injury, life support decisions can use more time

hotspot

WSS

Cancer researcher Catriona Jamieson is sending tumors into space

Flash flood warnings continue for parts of Missouri, Illinois

Google's generative AI to analyze medical images — and talk to docs

Getting Alzheimer's drug Leqembi to patients can be a challenge

Flash flood warnings continue for parts of Missouri, Illinois

Cholera vaccine supply gets boost as demand surges globally

entertainment

fashion

entertainment

The high cost of giving birth even with insurance

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

How to save PrEP access — and even expand it

Key Senate committee drafts bipartisan bill to stem drug shortages

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Failure, not just success, should guide future doctors

Drug repurposing or repositioning? The language matters

Why rehabilitation engineers need to center patients in their research

In Memoriam: Notable people who died in 2023

Doctors are clamoring for more clarity on Paxlovid prescribing

hotspot

Cancer researcher Catriona Jamieson is sending tumors into space

UnitedHealth financials solid despite Change Healthcare cyberattack

Why rehabilitation engineers need to center patients in their research

Judge in Trump's classified documents case questions use of out

Judge in Trump's classified documents case questions use of out

Failure, not just success, should guide future doctors

Wikipedia

hotspot

hotspot

hotspot